ORAMED PHARMACEUTICALS INC. Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Oramed Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Oramed Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 40.3M shares, a 0.07% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 40.3M -26.9K -0.07% Nov 7, 2024 10-Q 2024-11-07
Q2 2024 40.8M +493K +1.23% Aug 13, 2024 10-Q 2024-08-14
Q1 2024 40.5M +735K +1.85% Mar 6, 2024 10-K 2024-03-06
Q3 2023 40.3M +1.22M +3.13% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 40.3M +1.45M +3.73% Aug 10, 2023 10-Q 2023-08-10
Q1 2023 39.8M +1.22M +3.16% Mar 6, 2023 10-K 2023-03-06
Q3 2022 39.1M Nov 10, 2022 10-Q 2022-11-10
Q2 2022 38.8M +6.31M +19.4% Aug 10, 2022 10-Q 2022-08-10
Q1 2022 38.6M +8.34M +27.6% Mar 30, 2022 10-QT 2022-03-30
Q4 2021 38.3M +11.6M +43.6% Jan 11, 2022 10-Q 2022-01-11
Q2 2021 32.5M +8.99M +38.2% Jul 14, 2021 10-Q 2021-07-14
Q1 2021 30.2M +7.13M +30.9% Apr 13, 2021 10-Q 2021-04-13
Q4 2020 26.7M +8.93M +50.3% Jan 14, 2021 10-Q 2021-01-14
Q2 2020 23.5M +6.14M +35.3% Jul 7, 2020 10-Q 2020-07-07
Q1 2020 23.1M +5.71M +32.9% Apr 5, 2020 10-Q 2020-04-06
Q4 2019 17.7M +357K +2.06% Jan 9, 2020 10-Q 2020-01-09
Q2 2019 17.4M +20.7K +0.12% Jul 9, 2019 10-Q 2019-07-10
Q1 2019 17.4M +2.94M +20.3% Apr 9, 2019 10-Q 2019-04-10
Q4 2018 17.4M +3.01M +20.9% Jan 11, 2019 10-Q 2019-01-14
Q2 2018 17.4M +4.04M +30.3% Jul 11, 2018 10-Q 2018-07-12
Q1 2018 14.4M +1.15M +8.64% Apr 6, 2018 10-Q 2018-04-09
Q4 2017 14.4M +1.09M +8.19% Jan 10, 2018 10-Q 2018-01-11
Q2 2017 13.3M +184K +1.4% Jul 4, 2017 10-Q 2017-07-06
Q1 2017 13.3M +179K +1.36% Apr 4, 2017 10-Q 2017-04-05
Q4 2016 13.3M +188K +1.43% Jan 10, 2017 10-Q 2017-01-11
Q2 2016 13.1M +1.59M +13.7% Jul 5, 2016 10-Q 2016-07-06
Q1 2016 13.1M +2.29M +21.2% Apr 5, 2016 10-Q 2016-04-06
Q4 2015 13.1M +2.26M +20.9% Jan 12, 2016 10-Q 2016-01-13
Q2 2015 11.6M +1.59M +16% Jun 30, 2015 10-Q 2015-07-01
Q1 2015 10.8M +881K +8.86% Mar 31, 2015 10-Q 2015-04-03
Q4 2014 10.8M +1.09M +11.2% Jan 6, 2015 10-Q 2015-01-08
Q3 2014 10.1M Nov 12, 2014 10-K 2014-11-14
Q2 2014 9.96M +2.06M +26% Jul 11, 2014 10-Q 2014-07-14
Q1 2014 9.94M +2.72M +37.7% Apr 8, 2014 10-Q 2014-04-10
Q4 2013 9.75M -76.8M -88.7% Jan 13, 2014 10-Q 2014-01-14
Q2 2013 7.9M -62.6M -88.8% Jul 17, 2013 10-Q 2013-07-17
Q1 2013 7.22M -63.1M -89.7% Apr 10, 2013 10-Q 2013-04-11
Q4 2012 86.5M +16.3M +23.2% Dec 19, 2012 10-Q 2012-12-26
Q2 2012 70.5M Jul 11, 2012 10-Q 2012-07-12
Q1 2012 70.3M Apr 3, 2012 10-Q 2012-04-04
Q4 2011 70.2M Jan 10, 2012 10-Q 2012-01-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.